Safe Harbor Loci
Genomic sites where transgene integration does not disrupt endogenous gene function and supports stable, predictable expression.
Safe Harbor Loci are specific genomic regions where exogenous DNA can be integrated without disrupting essential gene functions and where inserted transgenes maintain reliable, long-term expression 1.
How It Works
Safe harbor loci meet several criteria: they are located away from oncogenes and tumor suppressors, are not within essential gene coding regions, reside in transcriptionally permissive chromatin, and do not disrupt regulatory elements that control nearby genes. The three best-characterized human safe harbors are AAVS1 (on chromosome 19), Rosa26, and CCR5.
Integration at these loci is typically achieved using site-specific nucleases (CRISPR-Cas9, ZFNs, or TALENs) paired with donor templates carrying the transgene flanked by homology arms matching the safe harbor sequence. The nuclease creates a double-strand break at the locus, and HDR incorporates the donor construct.
Safe harbors are critical for therapeutic gene therapy, where random integration risks insertional mutagenesis — the activation of oncogenes or disruption of tumor suppressors. They are also valuable in synthetic biology for constructing engineered cell lines with predictable transgene expression levels, avoiding the position effects and silencing associated with random integration 2.
Computational Considerations
Genome-wide computational screens identify candidate safe harbors by integrating criteria including distance from coding genes, absence of regulatory annotations, chromatin accessibility data, and replication timing. These analyses expand the repertoire of validated landing pads for diverse organisms and cell types 1.
Woolf Software builds computational tools for genome editing design and off-target prediction. Get in touch.
Bioinformatic criteria screen genomes for candidate safe harbors by analyzing gene density, chromatin openness, and proximity to oncogenes or essential genes.